• Exchange: EN Brussels
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma


4.0030 EUR 0.0430 1.09%

As of 11:35:00 ET on 09/19/2014.

Snapshot for MDxHealth (MDXH)

Open: 4.0100 Day's Range: 3.9700 - 4.0700 Volume: 48,623
Previous Close: 3.9600 52wk Range: 2.6500 - 5.2900 1-Yr Rtn: +44.51%

Stock Chart for MDXH

No chart data available.
  • MDXH:BB 4.0030
  • 1D
  • 1M
  • 1Y
Interactive MDXH Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for MDXH

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. BEL20 -
Earnings Per Share (EUR) (ttm) -0.2901
Est. EPS (EUR) (12/2014) -0.2730
Est. PEG Ratio -
Market Cap (M EUR) 137.11
Shares Outstanding (M) 34.25
30 Day Average Volume 88,201
Price/Book (mrq) -
Price/Sale (ttm) 23.8561
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/04/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for MDXH

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for MDXH

MDxHealth is a molecular diagnostics company that develops and commercializes oncology based molecular diagnostic testing for personalized medicine. The Company's tests are based on proprietary gene methylation technology and assist physicians and their patients with the accurate diagnosis of cancer, prognosis of recurrence risk and prediction of response to a specific therapy.

Jan GroenChief Executive OfficerFrancis OtaChief Financial Officer
Christopher ThibodeauExec VP:Commercial OpsJoseph SolleeExec VP:Corporate Dev & Legal
More Company Profile & Key Executives for MDXH

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil